Join the 'Zyclara' group to help and get support from people like you.
Zyclara News
Health Tip: Ward Off Infection From Ear Piercing
Posted 23 Jan 2017 by Drugs.com
-- Caring for pierced ears can help keep the piercings clean and prevent infection. Here is advice from the American Academy of Dermatologists: Never touch newly pierced ears without first washing your hands. Don't remove your first pair of earrings for at least six weeks. This helps the holes stay open. A few times each day, gently twist earrings around in your ears. At least once per day, wash ...
Retail Prices of Dermatology Drugs Skyrocket
Posted 25 Nov 2015 by Drugs.com
WEDNESDAY, Nov. 25, 2015 – Patients using prescription creams, gels, sprays and pills for skin conditions may shell out substantially more at the pharmacy than they did just six years ago, a new study suggests. Between 2009 and 2015, retail prices of brand-name dermatologic drugs rose 401 percent, on average, study authors reported Nov. 25 in JAMA Dermatology. Even generics have succumbed to ...
Rise in Vulvar Precancers Leads to New Guidelines
Posted 20 Oct 2011 by Drugs.com
THURSDAY, Oct. 20 – The number of American women with precancerous cells of the vulva increased more than fourfold between 1973 and 2000, and the increase has led to the release Thursday of new treatment guidelines by two major medical groups. Cancer of the vulva – the outside of the genital area – is usually caused by infection with human papillomavirus (HPV), which also causes cervical ...
FDA Approves Zyclara (imiquimod) Cream, 2.5% for the Treatment of Actinic Keratoses
Posted 29 Jul 2011 by Drugs.com
BRISTOL, Tenn.--(BUSINESS WIRE)--Jul 18, 2011 - Graceway Pharmaceuticals, LLC (Graceway) announced today that the Food and Drug Administration (FDA) has approved Zyclara Cream, 2.5% for the treatment of actinic keratoses, determining it to be safe and effective for the treatment of clinically typical, visible or palpable actinic keratoses (AK). The new formulation may be used on the full face or ...
FDA Approves Zyclara (imiquimod) Cream, 3.75% for the Treatment of External Genital Warts
Posted 27 Mar 2011 by Drugs.com
BRISTOL, Tenn.--(BUSINESS WIRE)--Mar 25, 2011 - Graceway Pharmaceuticals announced today that the Food and Drug Administration (FDA) has approved Zyclara Cream for the treatment of external genital and perianal warts (EGW) in patients 12 years of age and older. Zyclara Cream's clinical studies demonstrated that using its once-daily treatment regimen, for up to eight weeks, safely and effectively ...
Further Information
Related Condition Support Groups
Keratosis, Condylomata Acuminata
